United States · FDA National Drug Code directory
Fibromyalgia Relief
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17312-171_4604abd2-4b86-95d9-e063-6394a90a60d8
- Product NDC
- 17312-171
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- BRYONIA ALBA ROOT - CAUSTICUM - LOESELIA MEXICANA WHOLE - MAGNESIUM PHOSPHATE - PULSATILLA VULGARIS - TOXICODENDRON PUBESCENS LEAF - VALERIAN
- Labeler
- TRP Company
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20200528
- Source listing expiry
- 20261231
Source-listed ingredients
- LOESELIA MEXICANA WHOLE — 6 [hp_C]/1
- BRYONIA ALBA ROOT — 6 [hp_C]/1
- CAUSTICUM — 6 [hp_C]/1
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE — 6 [hp_C]/1
- PULSATILLA VULGARIS — 6 [hp_C]/1
- TOXICODENDRON PUBESCENS LEAF — 6 [hp_C]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 PACKAGE (17312-171-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE · 17312-171-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →